Profile data is unavailable for this security.
About the company
Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and sales of bulk pharmaceutical chemicals of chemical medicine and preparations. The Company’s products are on the spectrum from arthritis, dieresis to anti-virus and anti-tumor. The main products include bulk pharmaceutical chemicals, injections, capsules, intermediates and others.
- Revenue in CNY (TTM)676.85m
- Net income in CNY155.83m
- Incorporated2001
- Employees738.00
- LocationZhejiang Cheng Yi Pharmaceutical Co LtdNo. 118 Huagong Road, Dongtou DistrictSHANGHAI 201100ChinaCHN
- Phone+86 2 133283295
- Fax+86 2 133283305
- Websitehttp://www.chengyipharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Jiaoda Onlly Co Ltd | 280.54m | -39.86m | 2.07bn | 935.00 | -- | 7.10 | -- | 7.38 | -0.0514 | -0.0514 | 0.362 | 0.3761 | 0.3475 | 5.15 | 4.63 | 300,042.20 | -4.64 | -7.62 | -7.62 | -10.70 | 18.03 | 40.06 | -13.36 | -27.01 | 0.6301 | -1.40 | 0.3455 | -- | -21.43 | 2.65 | 92.96 | -- | -34.81 | -- |
| Frontier Biotechnologies Inc | 126.99m | -308.96m | 2.13bn | 395.00 | -- | 1.66 | -- | 16.78 | -0.8248 | -0.8248 | 0.339 | 3.44 | 0.0575 | 1.40 | 3.00 | 321,484.60 | -13.99 | -14.05 | -16.25 | -15.78 | 30.10 | 2.35 | -243.30 | -450.08 | 2.86 | -- | 0.2347 | -- | 34.82 | 126.63 | 7.79 | -- | 28.13 | -- |
| Shanghai Fudan Forward S&T Co Ltd | 665.16m | -6.01m | 2.15bn | 1.36k | -- | 2.70 | -- | 3.23 | -0.0089 | -0.0089 | 0.9791 | 1.16 | 0.3776 | 0.6066 | 8.47 | 488,010.90 | -0.3031 | -0.8781 | -0.5073 | -1.53 | 40.85 | 43.22 | -0.8027 | -1.85 | 0.4956 | -1.83 | 0.3817 | -- | -13.86 | -7.58 | 196.17 | -32.57 | -13.88 | -- |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 676.85m | 155.83m | 2.17bn | 738.00 | 13.87 | 1.77 | -- | 3.21 | 0.4781 | 0.4781 | 2.07 | 3.74 | 0.3666 | 1.92 | 11.71 | 917,147.40 | 8.40 | 12.01 | 10.14 | 14.75 | 63.88 | 69.79 | 22.92 | 22.84 | 1.21 | -- | 0.2589 | 36.44 | 2.54 | 4.24 | 0.8129 | 10.94 | -23.56 | 12.84 |
| Jiangsu Cowin Biotech Co Ltd | 123.20m | -117.37m | 2.21bn | 657.00 | -- | 1.36 | -- | 17.97 | -1.12 | -1.12 | 1.21 | 14.49 | 0.0664 | 1.33 | 1.23 | 187,520.90 | -6.63 | -- | -6.94 | -- | 58.15 | -- | -99.82 | -- | 14.37 | -- | 0.0184 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
Data as of Jun 14 2024. Currency figures normalised to Zhejiang Cheng Yi Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
8.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Post & Capital Fund Management Co., Ltd.as of 31 Dec 2023 | 5.00m | 1.53% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 4.48m | 1.37% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.90m | 1.19% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 2.39m | 0.73% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 2.34m | 0.71% |
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 2.08m | 0.64% |
| Cinda Fund Management Co. Ltd.as of 31 Dec 2023 | 2.03m | 0.62% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 1.78m | 0.55% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.77m | 0.54% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 1.04m | 0.32% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
